[1]
2024. Formulation and Evaluation of Extended-Release Bilayer Tablets Containing Empagliflozin and Metformin Hydrochloride for Diabetes Mellitus Management. International Journal of Pharmaceutical Sciences and Drug Research. 16, 5 (Sep. 2024), 777–787. DOI:https://doi.org/10.25004/IJPSDR.2024.160505.